Group 1: Company Orders and Financial Performance - The company has reported an increase in orders, with specific details available on the official website and WeChat account [2] - AI-related business revenue for the first half of the year reached 103 million CNY, with a positive outlook for the entire year [3] - Approximately 60% of AI revenue comes from the general ERP sector, while 40% is from intelligent manufacturing [3] Group 2: Product Development and Business Model - The company is set to launch a self-developed CAM software for the PCB industry next year [3] - The increase in contract assets is attributed to normal business operations and is not directly related to subscription or buyout models [3] Group 3: Investor Relations Activity - The investor relations activity was conducted online on September 19, 2025, with participation from the Chairman, General Manager, and Financial Director [2] - The event did not involve any undisclosed significant information [3]

Group 1: Shareholder Information - As of June 30, 2025, the total number of shareholders is 144,863 [2] Group 2: Company Performance and Future Plans - The company has planned ahead for its anime content, including films and related merchandise, to prepare for future performance improvements [2][3] - The company has not participated in the project related to the sale of 100,000 blind boxes [2] - The company is actively seeking to enhance its core competitiveness by learning from outstanding peers in the industry [3] Group 3: Risk and Compliance - The company does not face any delisting risk or other warning risks [3] - The employee stock ownership plan has been disclosed, and further details can be found in the relevant announcements [3] Group 4: Innovation and Content Development - The company adds thousands of minutes of new anime content each year, ranking high in the segmented industry for content volume [3] Group 5: Financial Forecast - Investors are advised to pay attention to the upcoming periodic reports for the third quarter and full-year performance forecasts [3]

4、公司半年报中提到的混合食材销售，具体是指哪些产品？ 您好！混合食材销售业务属于食品业板块，主要涵盖粮油、肉禽、水产、蔬菜、水果、 调味品等20个大类食材的全品类配送服务。该业务通过标准化流程实现规模化配送，覆盖信 宜市多家中小学及政府机关项目，服务6万余名师生用餐需求。"混合食材销售"业务是公司 向下游延伸，打通产业链的典型实践。感谢您的提问！ 5、"广弘3号"小白鸡在研发过程中有哪些创新举措，这些举措对品种成功培育有何意 义？ 广东广弘控股股份有限公司投资者关系活动记录表 编号：2025-03 | 投资者关系 | 特定对象调研 | □分析师会议 | □媒体采访 | | --- | --- | --- | --- | | 活动类别 | 业绩说明会 ☑ | □新闻发布会 | □路演活动 | | | 现场参观 | 电话会议 | 其他 | | 参与单位名称及人 | 投资者网上提问 | | | | 员名称 | | | | | 时间 | 2025年9月19日 (周五) 下午 15:30~17:00 | | | | 地点 | 公司通过全景网"投资者关系互动平台"（https://rs.p5w.net）采用网络 ...

Group 1: Company Performance and Financial Health - The company reported a significant decline in new orders for 2023-2024 due to a slowdown in the renewable energy sector and increased competition, leading to a decrease in project acceptance and losses in equipment business [3] - As of mid-2025, the company’s net assets were negative, attributed to industry cycles, and it is actively addressing this situation [4] - The company is focused on improving operational performance through technology innovation, increased R&D investment, and optimizing order structures [4][5] Group 2: Shareholder Concerns and Market Response - The recent forced sale of shares by a major shareholder has negatively impacted the company's stock price and investor confidence, but it is stated that this will not affect the company's operations [4] - The company is committed to enhancing shareholder value by concentrating on core business and improving product competitiveness [4] - There are ongoing discussions about potential strategic investors, with the company promising to disclose relevant information as per regulatory requirements [5] Group 3: Future Strategies and Developments - The company aims to strengthen its core business and expand its customer base while focusing on long-term development and value creation [3][5] - Plans for collaboration with Beijing Pure Lithium New Energy are in progress, with formal agreements to be disclosed in accordance with legal requirements [5] - The company is actively advancing research and development in solid-state battery technology and applications, emphasizing a strategy of "technological breakthroughs + ecological collaboration" [5]

债券代码：123090 债券简称：三诺转债 证券代码：300298 证券简称：三诺生物 三诺生物传感股份有限公司投资者关系活动记录表 编号：2025-09-01 | | □特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活动 | □媒体采访 □业绩说明会 | | 类别 | □新闻发布会 □路演活动 | | | □现场参观 | | | 其他（湖南辖区2025年投资者网上集体接待日暨半年度业绩说明会） | | 参与单位名称及 | 投资者均可登录"全景路演"网站（https://rs.p5w.net），或关注微信公众 | | 人员姓名 | 号：全景财经，或下载全景路演APP，参与本次互动交流 | | 时间 | 2025年9月19日 下午15:40—17:00 | | 地点 | 公司通过"全景路演"网站采用网络远程的方式参加"资本聚三湘 楚光耀 | | | 新程——2025年湖南辖区上市公司投资者网上集体接待日暨半年度业绩说 | | | 明会"活动 | | 上市公司接待 | 副总经理、董事会秘书：郑霁耘 | | 人员姓名 | 证券事务代表：许卉雨 | | | 公司就投资者在本次活动中提出的 ...

Group 1: Acquisition and Integration Plans - The company will complete the business registration change for the acquisition of Nanjing Hiroshima Technology Co., Ltd. by the end of September 2025, becoming its controlling shareholder [1] - Future integration efforts will focus on business synergy, resource integration, management enhancement, and strategic extension to enhance core competitiveness and profitability [2] Group 2: Business Collaborations and Market Position - The company is actively exploring collaborations in humanoid robotics and smart manufacturing, maintaining communication with upstream and downstream partners [3] - All acquisitions are aligned with the core business, focusing on automotive parts, automation, and humanoid robotics, with no plans for unrelated cross-industry projects [3] Group 3: Stock Performance and Market Management - The company's stock price is influenced by macroeconomic conditions, industry trends, and investor expectations, with no specific predictions on stock price fluctuations [5] - There is currently no stock incentive plan, but the company emphasizes long-term value creation and stable operations to reward shareholders [5] Group 4: Robotics Development and Future Projects - The company is in the preparatory phase for its robotics business, focusing on core component R&D and applications in automotive manufacturing and industrial automation [6] - The project for automotive hardware molds and humanoid robot arms is progressing as planned, with various permits obtained and construction expected to start by the end of September 2025 [9] Group 5: Investor Relations and Value Management - The company has established a long-term mechanism for market value management, focusing on improving information disclosure and investor relations [11] - Management remains confident in the company's business development and future prospects, aiming to return value to shareholders through operational performance [11]

Group 1: Company Performance and Future Plans - The company is currently seeking suitable acquisition targets to enhance its business operations [2][3] - There is an ongoing effort to improve operational performance, particularly in light of challenges posed by U.S. government sanctions [3] - The company has invested in Zhejiang Anxing Yulian Robot Co., Ltd. to diversify its business into robotics and intelligent perception devices [3] Group 2: Investor Relations and Communication - The company emphasizes the importance of maintaining effective communication with investors to build confidence in long-term stock holding [3] - Investors are encouraged to monitor future announcements on the company's performance through official channels [2][3] - The company is committed to enhancing its profitability and internal value through improved management practices [3] Group 3: Market Challenges - The company has faced significant impacts on its operations due to sanctions, which have affected its business activities [3] - There are inquiries regarding the company's exclusion from Huawei's R&D projects, which the company denies [3]

Group 1: Sales Performance - High-end beer sales increased by 14.16% in the first half of 2025, with new products like the 500mL can of "Jixiang Ruyi" and 980mL can of "Xuebao Craft White Beer" launched [2] - Revenue from supermarkets and e-commerce channels grew significantly, with e-commerce sales rising by 47% [2] Group 2: Financial Results - The company achieved a revenue of 3.198 billion yuan, representing a year-on-year growth of 7.09% [3] - Net profit attributable to shareholders reached 612 million yuan, marking a 22.51% increase compared to the previous year [3] Group 3: Operational Developments - The company is enhancing its "Beer + Cultural Tourism" strategy, focusing on improving the operational quality of "Zhujiang Pati" as a night economy landmark [3] - The new production line for bottled pure draft beer in Meizhou has been successfully launched, contributing to the optimization of production capacity and product structure [3] Group 4: Marketing and Digital Initiatives - The company is deepening the application of the O2O Phase II marketing digital empowerment project, which has improved management and sales at terminal stores [3] - Continuous efforts will be made to strengthen the management of accounts receivable and other receivables [3]

| 3、请祥细介绍公司核心业务覆铜板目前生产经营情况，包括 | | --- | | 但不于公司采取何措施降本增效和提高毛利率等情况，从而增 | | 加投资者投资公司股票信心！ | | 答：您好，目前公司核心业务覆铜板生产经营正常，公司通过 | | 客户结构优化，产品结构升级等方式在上半年实现了一定程度 | | 的毛利率提升，未来将进一步降本增效，整体提升盈利能力， | | 感谢关注。 | | 4、请问贵公司与东莞东城贤丰新能源科技项目有关吗？贵公 | | 司生产经营情况如何？贵公司何时采取符合规定的有效措施 | | 积极改善公司经营状况呢？ | | 答：您好，该项目非上市公司项目，目前公司主营业务为覆铜 | | 板和动保疫苗，经营情况正常开展。公司将积极开拓市场，并 | | 从内部的成本控制，质量提升等方式进一步降本增效来改善经 | | 营状况。感谢您的关注。 | | 5、请问董事长，贤丰控股集团的剩余股份 1.1415 亿股是否将 | | 被拍卖？将会如何处理？ | | 答：您好，公司会对控股股东及其一致行动人的股权变动事宜 | | 保持关注，并按照法律规定及公司章程的规定及时履行信息披 | | 露义务、保 ...

Group 1: Company Strategy and Market Position - The company aims to enhance investor confidence by actively expanding its product chain and strengthening its overseas marketing network to increase market share [2][3] - The company is a leading player in the domestic pharmaceutical equipment sector, with high technical content and automation levels in its products [3][4] - The company is considering innovative models such as equipment equity participation or leasing to boost market share [3] Group 2: Financial Performance and Shareholder Value - The company is focused on developing new products to meet customer demands and is actively securing domestic and international orders to improve operational performance [3] - The company reported significant growth in orders within the biopharmaceutical and vaccine production sectors, which are key strategic areas [3] - The company’s revenue contribution from new business expansions in the healthcare sector is detailed in its semi-annual report [3] Group 3: Technological Advancements - The company is enhancing its product intelligence through automation and smart manufacturing solutions, which improve production efficiency and product quality [4] - The company provides various information systems software to offer comprehensive smart manufacturing solutions to clients [4] Group 4: Investment and Partnerships - The company holds a 20% stake in Yantai Saibo Biotechnology Co., which is a minority investment and does not involve operational management [3] - The company’s subsidiary, Shanghai Bohao, is primarily focused on chip detection and single-cell sequencing, with no current plans to enter the brain-computer interface chip sector [3][4]